Dynocardia

Focus: Dynocardia is a biotechnology company developing cuff-less blood pressure monitoring technology focused on cardiovascular applications. The company is based in Cambridge, MA, a major pharma innovation hub.

Cardiovascular

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Dynocardia

AI assessmentNot Hiring

No open roles listed right now. Follow Dynocardia to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

ViTrack

Hypertension

N/A

Clinical Trials (1)

NCT04835857Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

N/A

Help build intelligence for Dynocardia

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage device/diagnostic company in high-value cardiovascular space with significant unmet need for non-invasive monitoring
Cambridge location provides proximity to top academic medical centers, venture capital, and biotech talent networks
Opportunity to shape product development and clinical strategy at pre-commercialization stage with direct impact on company trajectory

Watch Out For

Only 3 active job openings and minimal disclosed funding/headcount indicate very early stage with limited near-term hiring and growth visibility
No commercial revenue, published data, or disclosed trial results; stage of development and clinical validation timeline unclear
Engineering-focused hiring suggests heavy technical emphasis; unclear if your functional area (regulatory, clinical, commercial) is a priority

Generated by Claude from Dynocardia's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

ViTrack

Blood Pressure

N/A

Clinical Trials (1)

NCT04506775Comparison of Non-invasive and Invasive Blood Pressure Monitors

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Top TAs: Cardiovascular

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Cardiovascular

1 pipeline

Marketed

Pipeline